Top line at a three-year high, midcaps leading profit growth, margins holding
Every quarter, the aggregate of BSE500 earnings tells a story that individual stock reports cannot — a panoramic view of where Indian corporate India actually stands, stripped of the noise of any single company’s result. Nuvama’s Q4FY26 earnings aggregate is out, and the picture it paints is one of a market in genuine but uneven recovery, with pockets of strength sitting alongside pockets of vulnerability, and a consensus earnings forecast for FY27 that may be asking too much of an economy facing its own set of headwinds.
Decent, Not Dramatic
BSE500 (excluding oil marketing companies) delivered PAT growth of 12% year-on-year in Q4FY26 — a solid number that continues the recovery from the 8% growth posted in FY25. For the full year FY26, PAT growth came in at 9%. Not spectacular, but a genuine step up from the prior cycle.
The more interesting story is in the composition. Top line growth accelerated to 13% — a three-year high — driven by higher commodity prices, a weaker rupee and the tailwind from income tax cuts that put more money in consumers’ pockets. EBITDA growth, however, remained subdued at 7% — a gap that signals that revenue growth is not yet translating cleanly into operating profit, with input cost pressures and mix effects creating friction in the middle of the P&L. PAT growth of 12% was rescued by factors below the EBITDA line — interest cost management and tax dynamics — rather than pure operating leverage.
Within the quarter, metals and automobiles were the standout outperformers. Banks reported muted earnings. Industrials were, as Nuvama puts it, “a mixed bag.”
The Rebound
One of the most striking findings in Nuvama’s aggregate is the divergence in profit growth across market capitalisation segments in FY26. Midcaps posted profit growth of 21% — up sharply from 15% in FY25. Small caps delivered 11% — a dramatic improvement from just 2% in FY25. Large caps, meanwhile, remained subdued at 7%.
This is the data that underpins the narrative of SMID outperformance that has characterised much of the last twelve months. The earnings were there. The question — and Nuvama raises it explicitly — is whether the valuations in SMID stocks have now run too far ahead of what the earnings trajectory can sustain in FY27.
The Cashflow Warning
Buried in the aggregate, but important for investors who think about business quality rather than just reported earnings, is the cashflow picture. Operating cashflow growth for BSE500 (excluding OMCs and BFSI) slowed to 4% in FY26 — down from 11% in FY25. The slowdown was concentrated in cyclical companies, while consumer businesses posted better cashflows. Capex growth also moderated, to 10% year-on-year from 12% the prior year.
A widening gap between reported profits and operating cashflows is a signal worth taking seriously. It can reflect working capital build, aggressive revenue recognition, or simply the timing of large project milestones. Nuvama does not suggest anything is broken — but for investors in cyclical and industrial names specifically, this is a number to watch as FY27 unfolds.
At Inflection Points
Nuvama’s aggregate identifies four sectors where the direction of travel could change meaningfully in FY27 — and not all of them in the same direction.
Cement companies have pivoted from growth to profitability — cutting capex and focusing on margins. Nuvama suggests this strategic shift “could result in re-rating” as the market recognises the improved capital discipline. It is a constructive signal for a sector that has been under valuation pressure.
Industrial companies face the opposite dynamic. Order inflows have moderated sharply — particularly in the power segment — and margins have reached what Nuvama describes as “decadal highs.” Mean reversion in margins from these elevated levels, combined with slowing order momentum, “could potentially hurt high valuations.” For investors sitting on large gains in capital goods and industrial stocks, this is the most pointed warning in the entire note.
PSU banks disappointed despite a seemingly supportive backdrop of strong credit growth and low credit costs. The culprit was net interest margins — still under pressure — which prevented the strong loan growth from flowing through to earnings in the way investors had expected. “NIMs is now the key variable for PSU banks’ re-rating,” Nuvama states simply. Until margins stabilise or expand, the earnings leverage that justified premium valuations will remain elusive.
Chemicals and cement are also flagged as potential inflection stories — sectors where the worst of the cycle may be behind them and where improving fundamentals could drive earnings upgrades in the coming quarters.
The Consensus Problem
This is the most important part of Nuvama’s note for investors thinking about portfolio positioning. FY27 earnings estimates were trimmed by just 1% following the Q4 results season — a remarkably modest downgrade given the mixed earnings delivery. And yet consensus is still building in a 17% earnings CAGR over FY26-28 — compared to just 9% over FY24-26. That is a dramatic acceleration that requires a great deal to go right simultaneously.
“Weak income dynamics, corporate and government capex slowdown and oil supply shock” are the headwinds it cites. The West Asia crisis adds geopolitical uncertainty that could weigh on both commodity costs and export demand. “For FY27, the West Asia crisis amid weak incomes is likely to weigh on earnings,” the report states. “This could disappoint consensus estimates and weigh on equity returns, especially in SMIDs given high valuations.”
The tailwinds: a weak currency helps exporters and commodity-linked businesses, and rising credit growth provides a lift to financial sector earnings. But the base case that consensus has pencilled in looks optimistic relative to the macro environment.
The Report Card
| Metric | Q4FY26 | FY26 |
|---|---|---|
| BSE500 (ex-OMCs) PAT Growth | 12% YoY | 9% YoY |
| Top Line Growth | 13% YoY (3-year high) | 10% YoY |
| EBITDA Growth | 7% YoY | — |
| Midcap Profit Growth | — | 21% YoY |
| Small Cap Profit Growth | — | 11% YoY |
| Large Cap Profit Growth | — | 7% YoY |
| Operating Cashflow Growth | — | 4% YoY |
| FY27-28E Consensus PAT CAGR | — | 17% |
The honest read of Nuvama’s earnings aggregate is this: FY26 was a year of quiet recovery — decent but not exciting, with the real strength in midcaps and small caps rather than the large cap index. FY27 carries genuine risk that the consensus earnings recovery story — 17% CAGR, built on optimistic assumptions about income recovery, capex revival and margin expansion — may prove too ambitious.